Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Tomita Pharmaceutical Co., Ltd.
FDA Inspection
•Tomita Pharmaceutical Co., Ltd.•March 9, 2018

Tomita Pharmaceutical Co., Ltd. – FDA Inspection, Mar 9, 2018

Record Details

This FDA Inspection record concerns Tomita Pharmaceutical Co., Ltd., with an inspection on March 9, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.

Company
Tomita Pharmaceutical Co., Ltd.
Inspection Date
March 9, 2018
Product Type
Drugs
Office
Center for Drug Evaluation and Research
People
  • Jason R. Caballero (FDA Associated Person)
  • Vioela Respress (Issuing Officer)
View Company Profile

ID · c60f41d1-194c-40a9-b100-9e28bf1526c7

Inspection Facts

Voluntary Action Indicated (VAI)

Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.

Inspection number
1045598
FDA center
Human Drugs
Project area
Drug Quality Assurance
Outcome
Form 483 issued

FDA Citations

5
  1. 21 CFR 211.58Buildings not maintained in good state of repair
  2. 21 CFR 211.165(b)Microbiological testing
  3. 21 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
  4. 21 CFR 211.63Equipment Design, Size and Location
  5. 21 CFR 211.42(c)(1)Incoming material area

Full citation text and observation details available on the Dashboard.

Other FDA inspections of Tomita Pharmaceutical Co., Ltd.

7
DateClassificationOfficeProject area
May 23, 2025Not classifiedOffice of Inspections and Investigations
November 8, 2019NAICenter for Drug Evaluation and ResearchDrug Quality Assurance
July 29, 2016VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
November 1, 2013VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
November 1, 2013VAICenter for Food Safety and Applied NutritionFood Composition, Standards, Labeling and Econ
View all 7 other inspections on the company page
Other documents for Tomita Pharmaceutical Co., Ltd.
  • FDA Inspection 1274910 - 2025-05-23
  • FDA Inspection 1113539 - 2019-11-08
  • FDA Inspection 981352 - 2016-07-29
  • FDA Inspection 860359 - 2013-11-01
  • FDA Inspection 860351 - 2013-11-01

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Tomita Pharmaceutical Co., Ltd.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.